# Alternate Dosing Schedules Study for HPV Vaccine (ADS)

> **NCT02280642** · — · COMPLETED · sponsor: **Duke University** · enrollment: 331 (actual)

## Conditions studied

- Cervical Cancer
- Genital Warts

## Interventions

- **BIOLOGICAL:** Both 2nd and 3rd doses on time
- **BIOLOGICAL:** 2nd dose late and 3rd dose on time
- **BIOLOGICAL:** 2nd dose on time and 3rd dose late
- **BIOLOGICAL:** Both doses late

## Key facts

- **NCT ID:** NCT02280642
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 331 (ACTUAL)
- **Last updated:** 2014-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02280642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02280642, "Alternate Dosing Schedules Study for HPV Vaccine (ADS)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02280642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*